BerandaCAMX • STO
add
Camurus AB
Tutup sebelumnya
kr 633,50
Rentang hari
kr 629,00 - kr 647,00
Rentang tahun
kr 483,80 - kr 715,00
Kapitalisasi pasar
37,79Â M SEK
Volume Rata-Rata
260,33Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
STO
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (SEK) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 558,34Â jt | 43,17% |
Biaya operasional | 280,17Â jt | -0,10% |
Laba bersih | 197,25Â jt | 153,33% |
Margin laba bersih | 35,33 | 76,92% |
Penghasilan per saham | 3,29 | 149,24% |
EBITDA | 244,52Â jt | 196,95% |
Tarif pajak efektif | 22,33% | — |
Neraca
Total aset
Total liabilitas
| (SEK) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 2,88Â M | 26,57% |
Total aset | 3,97Â M | 29,68% |
Total liabilitas | 482,15Â jt | 16,16% |
Total ekuitas | 3,49 M | — |
Saham yang beredar | 58,64 jt | — |
Harga terhadap nilai buku | 10,65 | — |
Tingkat pengembalian aset | 15,46% | — |
Tingkat pengembalian modal | 17,31% | — |
Arus Kas
Perubahan kas bersih
| (SEK) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 197,25Â jt | 153,33% |
Kas dari operasi | 77,64Â jt | 113,70% |
Kas dari investasi | -34,14Â jt | -1.992,16% |
Kas dari pembiayaan | -6,10Â jt | -100,58% |
Perubahan kas bersih | 25,36Â jt | -97,66% |
Arus kas bebas | -23,22Â jt | -3.305,26% |
Tentang
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap.
Camurus was founded by scientists in biophysical, food, and pharmaceutical chemistry with expertise in lipid phase structures. The company provides nanoscale drug-delivery systems for development of high-value therapeutics. Wikipedia
Didirikan
1991
Situs
Karyawan
265
